You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Characterization of Opioid Receptors in Nervous Tissue [and Discussion]
H. W. Kosterlitz, S. J. Paterson and J. S. Morley
Proceedings of the Royal Society of London. Series B, Biological Sciences
Vol. 210, No. 1178, Neuroactive Peptides (Oct. 29, 1980), pp. 113-122
Published by: Royal Society
Stable URL: http://www.jstor.org/stable/35420
Page Count: 10
You can always find the topics here!Topics: Receptors, Morphine, Ileum, Vas deferens, Ligands, Binding sites, Opioid receptors, Agonists, Amides, Opioid peptides
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
The concept that endogenous opioid peptides interact with at least two different receptor sites developed from several experimental approaches. First, when the peptides were assayed by their effects on two pharmacological and two binding models, the rank order of activity differed in these four systems. Secondly, naloxone had a smaller antagonist effect on δ -receptors in the mouse vas deferens than on its μ -receptors. Thirdly, the enkephalins and morphine each occupied less than half of the total number of sites available in brain homogenates. Fourthly, cold ligands of the δ -type protected the binding of tritiated δ -agonists better than that of μ -agonists, and vice versa. Finally, tritiated ethylketazocine binds to κ -receptor sites in homogenates of guinea-pig brain. It is readily displaced by etorphine, which binds uniformly to μ -, δ - and κ -receptors, but only by very high concentrations of μ - or δ -agonists. An interesting phenomenon is the potentiation of activity when an enkephalin analogue is conjugated to tobacco mosaic virus by the group of R. Schwyzer.
Proceedings of the Royal Society of London. Series B, Biological Sciences © 1980 Royal Society